Scott B. Brown serves as Executive at Tracon Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Scott B. Brown has executed 7 insider transactions totaling $25.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 20, 2023 involved receiving (via award) 3,500 shares valued at $490.
Scott B. Brown currently holds 25,128 shares of Tracon Pharmaceuticals, Inc. (TCON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott B. Brown has been a net buyer of TCON stock. They have purchased $25.1K and sold $0 worth of shares.
Scott B. Brown's most recent insider trade was on Apr 20, 2023, when they sold 3,500 shares at $0.14 per share.
Get notified when new Form 4 filings are submitted
| $1.49 |
| Discretionary |
| Sep 12, 2022 | TCON | $5.0K | Purchase | 2,500 | $2.02 | Discretionary |
| Mar 29, 2022 | TCON | $2.8K | Purchase | 1,000 | $2.82 | Discretionary |
| Aug 13, 2021 | TCON | $3.7K | Purchase | 1,000 | $3.69 | Discretionary |
| Mar 8, 2021 | TCON | $8.3K | Purchase | 1,000 | $8.30 | Discretionary |
| Jan 22, 2020 | TCON | $68 | Payment | 18 | $3.76 | Discretionary |